Bisoprolol Market Report 2026

Bisoprolol Market Overview

• Bisoprolol market size has reached to $2.17 billion in 2025 • Expected to grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 8.5% • Growth Driver: Hypertension Surge Fuels Bisoprolol Market Growth As Deaths From Hypertensive Diseases Rise • Market Trend: Innovative Cardiovascular Therapies Aim To Improve Patient Outcomes And Adherence • North America was the largest region in 2025.

What Is Covered Under Bisoprolol Market?

Bisoprolol is a beta-blocker medication that helps manage high blood pressure, heart failure, and chest pain (angina). It works by blocking the effects of adrenaline on the heart, lowering heart rate and blood pressure, which reduces the heart’s workload. The main types of bisoprolol include tablets and capsules. The tablet form of bisoprolol is a solid, oral medication designed to treat cardiovascular conditions, offering a convenient, easy-to-administer option for patients, typically prescribed in specific doses that allow for controlled release of the medication over time. The distribution channels include hospital pharmacies, retail pharmacies, and others for applications such as high blood pressure, coronary heart disease, angina pectoris, and others.

What Is The Bisoprolol Market Growth Forecast?

The bisoprolol market size is expected to see strong growth in the next few years. It will grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising cardiovascular disease burden, increasing access to generic medicines, growth in outpatient cardiac management, expansion of pharmacy networks, improved treatment adherence programs. Major trends in the forecast period include rising prevalence of cardiovascular disorders, growing use of beta-blockers in chronic care, increased adoption of generic cardiovascular drugs, expansion of retail and hospital pharmacies, higher focus on long-term blood pressure management.

Global Bisoprolol Market Segmentation

1) By Type: Tablet, Capsule 2) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels 3) By Application: High Blood Pressure, Coronary Heart Disease, Angina Pectoris, Other Applications Subsegments: 1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets 2) By Capsule: Immediate-Release Capsules, Extended-Release Capsules, Hard Gelatin Capsules

What Is The Driver Of The Bisoprolol Market?

The increasing prevalence of hypertension is expected to propel the growth of the bisoprolol market going forward. Hypertension is a medical condition characterized by consistently elevated blood pressure levels above the normal physiological range. The prevalence of hypertension is increasing due to sedentary lifestyles and rising obesity rates. The bisoprolol market supports hypertension management by lowering blood pressure, reducing cardiac workload, and improving blood flow. For instance, in February 2024, according to the Singapore Ministry of Health, a Singapore-based government health authority, the prevalence of hypertension among adults reached 36.1% in 2023, rising from 33.0% in 2022, indicating a significant year-on-year increase. Therefore, the increasing prevalence of hypertension is driving the growth of the bisoprolol industry.

Key Players In The Global Bisoprolol Market

Major companies operating in the bisoprolol market are Merck & Co. Inc., Abbott Healthcare Pvt Ltd, Novartis AG, Teva Pharmaceutical Industries Ltd, Aurobindo Pharma Limited, Intas Pharmaceuticals Limited, Cipla Limited, Hikma Pharmaceuticals, Lupin Limited, Dr. Reddy’s Laboratories Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Ipca Laboratories Limited, Medreich Limited, Alembic Pharmaceuticals Limited, Accord Healthcare Limited, Zydus Lifesciences Limited, Zentiva Group, Taj Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Suanfarma, Rusan Healthcare Limited, VHB Lifesciences Limited, Synnat Pharmaceuticals, Vidakem Lifesciences Pvt Ltd, Pluviaendo Pharmaceuticals

Global Bisoprolol Market Trends and Insights

Major companies operating in the bisoprolol market are focusing on developing innovative solutions, such as fixed-dose combinations and extended-release formulations, to improve patient adherence, enhance cardiovascular outcomes, and address limitations of conventional therapies. Fixed-dose combinations are medications that combine two or more active drugs in a single pill to simplify treatment, while extended-release formulations are designed to release the drug slowly over time for longer-lasting effects and reduced dosing frequency. For instance, in June 2025, Cadila Pharmaceuticals Limited, an India-based pharmaceutical company, launched Biscado (Bisoprolol) in India, entering the beta-blocker therapy segment for managing cardiovascular diseases. It is a highly cardioselective beta-1 adrenergic blocker indicated for treating high blood pressure, angina, and chronic heart failure by reducing heart rate and blood pressure to ease strain on the heart. It is clinically supported with studies showing significant reductions in mortality, sudden cardiac death, and hospitalizations for heart failure. Biscado is available in once-daily dosing and fixed-dose combinations with other antihypertensive agents, aligning with global cardiovascular treatment guidelines and improving patient adherence in India.

What Are Latest Mergers And Acquisitions In The Bisoprolol Market?

In April 2023, SK Capital Partners LP, a US-based private investment firm specializing in specialty materials, chemicals, and pharmaceuticals, acquired Apotex Inc. for an undisclosed amount. This acquisition strengthens Apotex’s ability to expand its global capabilities by leveraging SK Capital’s operational expertise and resources to accelerate growth and innovation. It further enhances Apotex’s capacity to deliver high-quality, affordable medicines worldwide through improved manufacturing, R&D investment, and strategic market expansion. Apotex Inc. is a Canada-based pharmaceutical company and manufacturer of bisoprolol.

Regional Insights

North America was the largest region in the bisoprolol market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bisoprolol Market?

The bisoprolol market consists of sales of generic medicine, extended-release tablets, and oral solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bisoprolol Market Report 2026?

The bisoprolol market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bisoprolol industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.